Nissim Darvish - Net Worth and Insider Trading
Nissim Darvish Net Worth
The estimated net worth of Nissim Darvish is at least $2,202 dollars as of 2024-11-13. Nissim Darvish is the Director of Chemomab Therapeutics Ltd and owns about 1,200 shares of Chemomab Therapeutics Ltd (CMMB) stock worth over $2,202. Details can be seen in Nissim Darvish's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nissim Darvish has not made any transactions after 2022-03-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Nissim Darvish
Nissim Darvish Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nissim Darvish owns 2 companies in total, including 9 Meters Biopharma Inc (NMTRQ) , and Chemomab Therapeutics Ltd (CMMB) .
Click here to see the complete history of Nissim Darvish’s form 4 insider trades.
Insider Ownership Summary of Nissim Darvish
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
NMTRQ | 9 Meters Biopharma Inc | 2020-04-30 | director & 10 percent owner |
CMMB | Chemomab Therapeutics Ltd | 2022-03-11 | director |
Nissim Darvish Latest Holdings Summary
Nissim Darvish currently owns a total of 1 stock. Nissim Darvish owns 1,200 shares of Chemomab Therapeutics Ltd (CMMB) as of March 11, 2022, with a value of $2,202.
Latest Holdings of Nissim Darvish
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CMMB | Chemomab Therapeutics Ltd | 2022-03-11 | 1,200 | 1.84 | 2,202 |
Holding Weightings of Nissim Darvish
Nissim Darvish Form 4 Trading Tracker
According to the SEC Form 4 filings, Nissim Darvish has made a total of 1 transactions in Chemomab Therapeutics Ltd (CMMB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Chemomab Therapeutics Ltd is the acquisition of 1,200 shares on March 11, 2022, which cost Nissim Darvish around $5,136.
Insider Trading History of Nissim Darvish
- 1
Nissim Darvish Trading Performance
GuruFocus tracks the stock performance after each of Nissim Darvish's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nissim Darvish is -10%. GuruFocus also compares Nissim Darvish's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nissim Darvish within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nissim Darvish's insider trading performs compared to the benchmark.
Performance of Nissim Darvish
Nissim Darvish Ownership Network
Ownership Network List of Nissim Darvish
Ownership Network Relation of Nissim Darvish
Nissim Darvish Owned Company Details
What does 9 Meters Biopharma Inc do?
Who are the key executives at 9 Meters Biopharma Inc?
Nissim Darvish is the director & 10 percent owner of 9 Meters Biopharma Inc. Other key executives at 9 Meters Biopharma Inc include Chief Financial Officer Bethany Sensenig , director & Chief Executive Officer John Temperato , and Chief Financial Officer Edward J Sitar .
9 Meters Biopharma Inc (NMTRQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of 9 Meters Biopharma Inc (NMTRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of 9 Meters Biopharma Inc (NMTRQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
9 Meters Biopharma Inc (NMTRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
9 Meters Biopharma Inc Insider Transactions
Nissim Darvish Mailing Address
Above is the net worth, insider trading, and ownership report for Nissim Darvish. You might contact Nissim Darvish via mailing address: C/o Innovate Biopharmaceuticals, Inc., 8480 Honeycutt Road, Suite 120, Raleigh Nc 27615.